 |
A clinical trial has been listed proposing the combination of Mirvaso and Dysport (the Galderma owned Botox-like product) to treat the redness and flushing of rosacea. So if you have ever wondered whether botox and Mirvaso might work well together, this trial is for you.
The trial will examine how well the combination of Mirvaso and Dysport affects both erythema and flushing 6 months after the treatment is administered.
This may represent a viable new treatment option for treatment resistent rosacea redness. Botox blocks the release of acetylcholine, a neural transmitter that is part of the autonomic nervous system.
Clinical Trial NCT03508869
Mirvaso Gel and Dysport for Erythema and Flushing of Rosacea
To assess the improvement of facial erythema and flushing while using Mirvaso and Dysport treatments based on the clinician’s and patient’s assessments using a verified 5-point grading scale.
- Sponsor: Skin Laser & Surgery Specialists
- Collaborator: Galderma
- Information provided by (Responsible Party): David J. Goldberg, MD, Skin Laser & Surgery Specialists
Mirvaso (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent facial erythema of rosacea in adults 18 years of age or older.Dysport is an acetylcholine release inhibitor and a neuromuscular blocking agent.Other Name: Dysport (abobotulinumtoxinA)
Dr. Goldberg is well known to rosacea sufferers through the following highlighted articles – Combining Light-Based Treatments and Topicals for Rosacea, and also his book Acne and Rosacea: Epidemiology, Diagnosis and Treatment
[Update:] the trial has been listed as suspended by sponsor request. Not enough participants were able to be found so the trial has been abandoned.
Forget the drugs…try Dr Steven Gundry’s Paradox Program found in his book “The Plant Paradox” published April 2017. No more Rosacea!
Hi Marge, Where do you get this book please, I have tried everything that has been recommended with no good results.
I’d like to participate in this trial.